Prevalence of hepatitis among young men who have sex with men and transgender women in Brazil

OBJECTIVE: Viral hepatitis and sexually transmitted infections disproportionally affect men who have sex with men (MSM) and transgender women (TGW). However, only a few studies have evaluated the prevalence of hepatitis in these populations, especially in youths and adolescents. This study aimed to estimate the prevalence of biomarkers for hepatitis A, B, and C among young and adolescent MSM and TGW in three Brazilian municipalities. METHODS: Baseline data were collected from a combination of HIV prevention cohort ofyoung and adolescent MSM (AMSM) and TGW (ATGW) aged 15-19 years in three Brazilian municipalities. A social behavioral questionnaire was applied, and immunoassays were performed to detect antibodies against hepatitis A (anti- HAV IgG and IgM), hepatitis B (anti-HBc and anti-HBs), and hepatitis C virus (anti-HCV); testing for the active hepatitis B marker, HBsAg, was also performed. The prevalence of reactive tests and 95% confidence interval (CI) for proportions were measured. RESULTS: The prevalence of naturally or artificially acquired immunity for hepatitis A totaled 17.7% (95%CI: 15.4–20.4), whereas that of acute infection, 0.4% (95%CI: 0.2–1.2). For hepatitis B and C, prevalence rates totaled 2.8% (95%CI: 1.8–4.4) and 0.2% (95%CI: 0.1–1.1), respectively. About 25.7% (95%CI: 22.4–29.4) of participants were non-reactive for anti-HBc and reactive for anti-HBs, the latter being a vaccine marker for hepatitis B. CONCLUSIONS: The investigation of viral hepatitis biomarkers among vulnerable populations enables the early identification of infections, the provision of timely treatment, and an opportunity to point out the need to expand vaccination coverage.

Authors

Institutions

Publication Details

Journal
Revista de Saúde Pública
Published
2024-12-12
DOI
https://doi.org/10.11606/s1518-8787.2024058005555
Primary Topic
HIV/AIDS Research and Interventions
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prevalence of hepatitis among young men who have sex with men and transgender women in Brazil

Beo Oliveira Leite, Daniel Lima de Moura, Mateus Rodrigues Westin, Laio Magno et al.
1 links
Revista de Saúde Pública
HIV/AIDS Research and Interventions
article

Prevalence of hepatitis among young men who have sex with men and transgender women in Brazil

Beo Oliveira Leite, Daniel Lima de Moura, Mateus Rodrigues Westin, Laio Magno, Carina Carvalho dos Santos, Fernanda Washington de Mendonça Lima, Alexandre Grangeiro, Inês Costa Dourado
article en

Abstract

OBJECTIVE: Viral hepatitis and sexually transmitted infections disproportionally affect men who have sex with men (MSM) and transgender women (TGW). However, only a few studies have evaluated the prevalence of hepatitis in these populations, especially in youths and adolescents. This study aimed to estimate the prevalence of biomarkers for hepatitis A, B, and C among young and adolescent MSM and TGW in three Brazilian municipalities. METHODS: Baseline data were collected from a combination of HIV prevention cohort ofyoung and adolescent MSM (AMSM) and TGW (ATGW) aged 15-19 years in three Brazilian municipalities. A social behavioral questionnaire was applied, and immunoassays were performed to detect antibodies against hepatitis A (anti- HAV IgG and IgM), hepatitis B (anti-HBc and anti-HBs), and hepatitis C virus (anti-HCV); testing for the active hepatitis B marker, HBsAg, was also performed. The prevalence of reactive tests and 95% confidence interval (CI) for proportions were measured. RESULTS: The prevalence of naturally or artificially acquired immunity for hepatitis A totaled 17.7% (95%CI: 15.4–20.4), whereas that of acute infection, 0.4% (95%CI: 0.2–1.2). For hepatitis B and C, prevalence rates totaled 2.8% (95%CI: 1.8–4.4) and 0.2% (95%CI: 0.1–1.1), respectively. About 25.7% (95%CI: 22.4–29.4) of participants were non-reactive for anti-HBc and reactive for anti-HBs, the latter being a vaccine marker for hepatitis B. CONCLUSIONS: The investigation of viral hepatitis biomarkers among vulnerable populations enables the early identification of infections, the provision of timely treatment, and an opportunity to point out the need to expand vaccination coverage.

Revista de Saúde PúblicaVol. 58(Supl.1)
Universidade Federal de Minas Gerais (BR), Universidade Federal da Bahia (BR), Universidade do Estado da Bahia (BR), Universidade de São Paulo (BR), Instituto de Saúde (BR), Universidade Salvador (BR)
World Health Organization, Ministério da Saúde, Fundação Oswaldo Cruz, Foundation for Scientific and Technological Development in Health
Openalex Percentile: Top 68%
HIV/AIDS Research and Interventions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.